Related Experiment Video
Updated: Mar 26, 2026

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
Published on: August 19, 2025
Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using
Abigail S Caudle1, Wei T Yang1, Savitri Krishnamurthy1
1All authors: The University of Texas MD Anderson Cancer Center, Houston, TX.
Clipping breast cancer nodes with metastasis before neoadjuvant therapy and using targeted axillary dissection (TAD) significantly reduces the false-negative rate (FNR) for nodal staging. This approach improves accuracy in evaluating residual disease after chemotherapy.
Area of Science:
- Oncology
- Surgical Pathology
- Breast Cancer Research
Background:
- Accurate staging of breast cancer nodal metastasis is crucial for treatment planning.
- Neoadjuvant therapy is increasingly used, necessitating reliable methods to assess treatment response in lymph nodes.
- Sentinel lymph node dissection (SLND) alone can have a significant false-negative rate (FNR).
Purpose of the Study:
- To evaluate if pathologic changes in clipped nodes correlate with overall nodal basin status after neoadjuvant therapy.
- To determine if targeted axillary dissection (TAD), incorporating SLND and clipped node removal, improves the FNR compared to SLND alone.
- To assess the utility of clip placement in biopsy-confirmed metastatic nodes for guiding axillary surgery.
Main Methods:
- Prospective study involving patients with biopsy-confirmed nodal metastases and a placed clip in the sampled node.
- Post-neoadjuvant therapy, patients underwent axillary surgery, comparing clipped node pathology with other nodes.
- Targeted axillary dissection (TAD) involved SLND and selective removal of the clipped node using iodine-125 seed localization.
- False-negative rates were calculated in patients undergoing complete axillary lymphadenectomy (ALND).
Main Results:
- Of 191 patients undergoing ALND, 120 (63%) had residual disease. The clipped node identified metastases in 115 patients (FNR 4.2%).
- In patients undergoing SLND and ALND (n=118), the FNR was 10.1%. Incorporating clipped node evaluation reduced the FNR to 1.4% (P=.03).
- The clipped node was not retrieved as an SLN in 23% of patients, highlighting its importance for targeted removal. TAD followed by ALND yielded an FNR of 2.0%.
Conclusions:
- Marking biopsy-confirmed metastatic nodes with clips enables selective removal and enhances pathologic assessment of residual nodal disease post-chemotherapy.
- Targeted axillary dissection, including evaluation of clipped nodes, significantly lowers the false-negative rate in breast cancer nodal staging.
- Clip placement is a valuable tool for improving the accuracy of axillary staging after neoadjuvant therapy.
More Related Videos
13:35Endoscopic Bilateral Nipple-sparing Mastectomy via a Single Axillary Incision with Immediate Pre-pectoral Implant-based Breast Reconstruction
Published on: May 17, 2024
07:51The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019